Published in Oncogene on February 03, 2000
Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research | NCT01556178
Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science (2011) 4.76
Prognostic importance of survivin in breast cancer. Br J Cancer (2003) 1.56
Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Mol Cancer (2011) 1.26
Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. Neoplasia (2004) 1.21
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. BMC Cancer (2012) 1.17
Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy. J Neurooncol (2008) 1.14
Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am J Pathol (2004) 1.13
Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction. Neoplasia (2008) 1.11
Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis. Mol Biol Cell (2009) 1.08
Survivin expression and serum levels in pancreatic cancer. World J Surg Oncol (2015) 1.06
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models. Leukemia (2011) 1.06
Survivin expression and its clinical significance in pancreatic cancer. BMC Cancer (2005) 1.05
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors. Pediatr Clin North Am (2010) 1.04
Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol (2001) 1.03
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma. Cancer Immunol Immunother (2012) 1.02
The connections between neural crest development and neuroblastoma. Curr Top Dev Biol (2011) 1.01
Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis. PLoS One (2013) 0.98
Neuroblastoma. Semin Pediatr Surg (2012) 0.97
cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol (2006) 0.95
Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol (2006) 0.92
Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors. Clin Cancer Res (2012) 0.92
Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications. Neoplasia (2006) 0.91
Survivin as a prognostic factor for osteosarcoma patients. Acta Histochem Cytochem (2006) 0.91
Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. Neuro Oncol (2010) 0.90
Antitumor cytotoxic T-cell response induced by a survivin peptide mimic. Cancer Immunol Immunother (2010) 0.90
Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin. Invest New Drugs (2010) 0.89
BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma. Oncogene (2015) 0.88
Therapeutic targets for neuroblastomas. Expert Opin Ther Targets (2014) 0.87
Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Exp Cell Res (2012) 0.86
Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma. Cancer Immunol Immunother (2008) 0.86
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy. BMC Cancer (2012) 0.86
Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors. Bioengineered (2012) 0.85
Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol (2008) 0.85
A 6-gene signature identifies four molecular subgroups of neuroblastoma. Cancer Cell Int (2011) 0.84
Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas. Virchows Arch (2004) 0.84
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. Br J Cancer (2012) 0.84
In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide. Nanoscale Res Lett (2014) 0.83
Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res (2011) 0.83
Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma. PLoS One (2013) 0.83
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer. J Transl Med (2006) 0.83
Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth. J Cancer Res Clin Oncol (2012) 0.82
Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib. Oncotarget (2016) 0.81
The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention. Cancer Chemother Pharmacol (2010) 0.81
Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies. J Cancer Res Clin Oncol (2014) 0.80
Apoptotic cell death in neuroblastoma. Cells (2013) 0.79
Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. World J Gastroenterol (2011) 0.78
Immunotherapy for pediatric cancer. Biol Blood Marrow Transplant (2008) 0.77
A cell-based high-throughput screen addressing 3'UTR-dependent regulation of the MYCN gene. Mol Biotechnol (2014) 0.77
Expression level of quiescin sulfhydryl oxidase 1 (QSOX1) in neuroblastomas. Eur J Histochem (2014) 0.77
Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm. BMC Med Genomics (2015) 0.77
Rapamycin induces the anti-apoptotic protein survivin in neuroblastoma. Int J Biochem Mol Biol (2012) 0.76
Membrane microdomain-associated uroplakin IIIa contributes to Src-dependent mechanisms of anti-apoptotic proliferation in human bladder carcinoma cells. Biol Open (2012) 0.76
How to target apoptosis signaling pathways for the treatment of pediatric cancers. Front Oncol (2013) 0.76
Research progress of neuroblastoma related gene variations. Oncotarget (2016) 0.75
Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma. Oncotarget (2016) 0.75
Serum survivin increases in prolactinoma. J Clin Med Res (2015) 0.75
Neuroblastoma treatment in the post-genomic era. J Biomed Sci (2017) 0.75
Mitochondrial survivin - an Achilles' heel in cancer chemoresistance. Mol Cell Oncol (2015) 0.75
Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart. BMC Vet Res (2017) 0.75
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. Cell Mol Biol Lett (2017) 0.75
Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation. Oncotarget (2017) 0.75
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science (1997) 13.67
Engineered GFP as a vital reporter in plants. Curr Biol (1996) 9.03
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science (1997) 8.95
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (2000) 6.24
Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A (1983) 5.00
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci U S A (1991) 4.96
Thermosensitive replication of a kanamycin resistance factor. J Bacteriol (1967) 4.46
Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J Clin Invest (1981) 4.46
Signal transduction in the phosphate regulon of Escherichia coli involves phosphotransfer between PhoR and PhoB proteins. J Mol Biol (1989) 3.56
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med (1998) 3.23
ATP-linked calcium transport in cells and membrane vesicles of Streptococcus faecalis. J Biol Chem (1978) 3.14
The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem (1999) 3.14
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A (1991) 3.12
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med (1983) 3.04
The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J (1993) 3.00
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A (1998) 2.96
An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet (1996) 2.89
Non-invasive quantitative detection and applications of non-toxic, S65T-type green fluorescent protein in living plants. Plant J (1999) 2.88
A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. J Immunol Methods (1983) 2.75
Oxidative degradation of squalene by Arthrobacter species. Appl Microbiol (1975) 2.73
A proton-translocating ATPase regulates pH of the bacterial cytoplasm. J Biol Chem (1985) 2.71
Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res (2000) 2.61
Regulation of the cytoplasmic pH in Streptococcus faecalis. J Biol Chem (1982) 2.61
Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun (1994) 2.60
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet (2001) 2.55
Novel hyaluronidase from streptomyces. Biochim Biophys Acta (1970) 2.52
Giant Rashba-type spin splitting in bulk BiTeI. Nat Mater (2011) 2.49
Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci U S A (1994) 2.44
NAK is an IkappaB kinase-activating kinase. Nature (2000) 2.44
The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun (1998) 2.41
Infinite-layer iron oxide with a square-planar coordination. Nature (2007) 2.41
Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial fimbriae. Arch Oral Biol (1988) 2.39
Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem (1991) 2.36
Green-fluorescent protein as a new vital marker in plant cells. Plant J (1995) 2.28
Unique morphology of the human eye. Nature (1997) 2.27
Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst (1994) 2.25
Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates. J Clin Invest (1982) 2.23
Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys (2000) 2.21
DNA methylation as a mechanism of transcriptional regulation in nonphotosynthetic plastids in plant cells. Proc Natl Acad Sci U S A (1988) 2.19
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res (1984) 2.17
Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol (1998) 2.14
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer (2009) 2.13
Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy. Clin Nephrol (1990) 2.09
Temperature sensitivity of cell growth in Escherichia coli associated with the temperature sensitive R(KM) factor. Nature (1968) 2.09
The number of ribosomal RNA genes in Mycoplasma capricolum. Mol Gen Genet (1981) 2.08
The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s. Cell Stress Chaperones (2000) 2.05
Streptococcal cytoplasmic pH is regulated by changes in amount and activity of a proton-translocating ATPase. J Biol Chem (1986) 2.03
Copper proteins and oxygen. Correlations between structure and function of the copper oxidases. J Gen Physiol (1965) 2.02
Lysenin, a novel sphingomyelin-specific binding protein. J Biol Chem (1998) 2.02
Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol (1997) 2.02
Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels. Neuron (1996) 1.98
DNA binding of PhoB and its interaction with RNA polymerase. J Mol Biol (1996) 1.97
A glycine-rich RNA-binding protein mediating cold-inducible suppression of mammalian cell growth. J Cell Biol (1997) 1.95
Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res (1979) 1.93
Construction and characterization of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins. DNA Res (1997) 1.92
Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity (2000) 1.92
Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain. J Biol Chem (1998) 1.90
Field test of quantum key distribution in the Tokyo QKD Network. Opt Express (2011) 1.89
Nodule initiation elicited by noninfective mutants of Rhizobium phaseoli. J Bacteriol (1985) 1.89
Genes affecting the productivity of alpha-amylase in Bacillus subtilis Marburg. J Bacteriol (1975) 1.88
Identification of the genetic locus for the structural gene and a new regulatory gene for the synthesis of repressible alkaline phosphatase in Saccharomyces cerevisiae. Mol Cell Biol (1982) 1.88
Treatment of gallbladder cancer by radical resection. Br J Surg (1999) 1.88
Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1997) 1.87
Amplification of the Streptococcus faecalis proton-translocating ATPase by a decrease in cytoplasmic pH. J Bacteriol (1984) 1.87
Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol (1988) 1.85
The incidence of simple renal cyst by computed tomography. Clin Radiol (1983) 1.82
A non-specific lipid transfer protein from Arabidopsis is a cell wall protein. Plant J (1993) 1.81
A NotI restriction map of the entire long arm of human chromosome 21. Nat Genet (1993) 1.80
Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci U S A (1994) 1.78
Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur J Biochem (1991) 1.77
Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol (1991) 1.74
Pressure-dependent metallic and superconducting phases in a germanium artificial metal. Phys Rev Lett (2009) 1.73
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology (2006) 1.73
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
Actions of noradrenaline and acetylcholine on sympathetic ganglion cells. J Physiol (1970) 1.72
Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology (1999) 1.72
Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res (1995) 1.71
Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol (1999) 1.71
Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol (1984) 1.70
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
Clinical features of symptomatic Rathke's cleft cyst. Clin Neurol Neurosurg (2001) 1.68
Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene (1999) 1.68
Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res (2001) 1.67
Streptococcus faecalis mutants defective in regulation of cytoplasmic pH. J Bacteriol (1980) 1.67
Relation of spontaneous passage of ureteral calculi to size. Urology (1977) 1.67
Archaeal adaptation to higher temperatures revealed by genomic sequence of Thermoplasma volcanium. Proc Natl Acad Sci U S A (2000) 1.67
Nestin expression in the kidney with an obstructed ureter. Kidney Int (2007) 1.66
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia (1997) 1.66
Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma. Oncogene (2010) 1.65
Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension (1996) 1.65
Congenital primitive neuroectodermal tumor with epithelial and glial differentiation. An ultrastructural and immunohistochemical study. Arch Pathol Lab Med (1990) 1.65
Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics (1999) 1.64
Purification and properties of nitroalkane oxidase from Fusarium oxysporum. J Bacteriol (1978) 1.62
RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res (1998) 1.62